Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06598722
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-03
Brief Title:
BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemialymphoma
Sponsor:
Organization:
None